Many of you will be reading this at around the time of the third European Stroke Organization Conference meeting, in Prague. It is timely to reflect on how successful this meeting has become in such a short period, very capably led initially by Kennedy Lees and now Valeria Caso. It has become the focus of the everincreasing research output of European investigators, and forms a nice counterbalance between major meetings on the North American continent and the Asia Pacific region. Of course the World Stroke Congress links these events nicely with global agenda and reach, the coming meeting in Montreal 2018. You'll be interested to know that we attend and collect podcast interviews, which we host on our podbean page (ijspodcasts.podbean.com), and invite various experts to tweet on our behalf @IntJStroke, to keep up to date please follow us.
The importance of collaterals in acute ischemic stroke is emphasized in the report by David Liebskind of Collaterals 2016 (3rd International Symposia on Colleterals to the Brain). With modern imaging technology, the role that is played by collaterals is becoming much better understood, particularly in terms of prognosis and responsiveness to therapies; thrombolysis and thrombectomy. The vigor with which the meeting is being regularly conducted would suggest that we are likely to make even more significant advances in this area in the near future.
We have two interesting papers from Germany in this edition concerning anticoagulants, the first by Uphaus et al. who used a retrospective analysis of their databank to show that is was possible to undertake endovascular therapy in the presence of anticoagulants, a useful and practical finding given that this is a dilemma faced by many practising clinicians. Perhaps as a sign of the changing times, the paper by Diener et al. demonstrates that by reversing the NOAC dabigatran with idarucizumab prior to treatment with IV thrombolysis, no serious complications occurred. Further, when given to patients with intracerebral hemorrhage, the proof of principal of safe administration and reasonable outcome was established.
All in all another excellent edition, I look forward to seeing you all in Prague!
